QA: RENOVARO BIOSCIENCES INC. in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001527728_2021_RENOVARO_BIOSCIENCES_INC.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001527728')"}

Graph

Absolute values for 0001527728, RENOVARO BIOSCIENCES INC.

  xvar xval
0 AssetsCurrent 8,941,209
1 IntangibleAssetsNetIncludingGoodwill 11,717,323
2 PropertyPlantAndEquipmentNet 778,118
3 remainder_Assets 156,665,409
4 LiabilitiesCurrent 1,334,798
5 LiabilitiesNoncurrent 1,531,779
6 remainder_Liabilities 8,963,221
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 7,120,835
9 ResearchAndDevelopmentExpense 4,694,349
10 remainder_Expenses 108,584
11 remainder_Revenues 0
12 remainder_NetIncome 507,410
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 178,102,059
1 Liabilities 11,829,798
2 Expenses 11,923,768
3 Revenues 0
4 StockholdersEquity 166,272,261
5 NetIncome -11,416,358
6 ComprehensiveNetIncome -11,416,358
7 BaseVar 101,181,518
8 EconomicCapitalRatio 2.89

Edgar->Model Mapping

Feature Distribution

Change over Time